Evidence map›Paper›PMID 36565323›Full record

ArticleEuropean journal of pediatrics2023

Hearing screening test in neonates born to COVID-19-positive mothers.

Anastasios Goulioumis, Maria Angelopoulou, Konstantinos Kourelis, Konstantinos Mourtzouchos, Magdalini Tsiakou, Athanasios Asimakopoulos

Open access · bronzeAbstract read
In one paragraph

Article in European journal of pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anastasios GoulioumisDepartment of Otorhinolaryngology, Pediatric Hospital "Karamandanio", Erythrou Stavou 40, 26331, Patras, Greece. goulioum@upatras.gr.ORCID http://orcid.org/0000-0003-3178-2618
Maria AngelopoulouDepartment of Otorhinolaryngology, Pediatric Hospital "Karamandanio", Erythrou Stavou 40, 26331, Patras, Greece.
Konstantinos KourelisDepartment of Otorhinolaryngology, Pediatric Hospital "Karamandanio", Erythrou Stavou 40, 26331, Patras, Greece.
Konstantinos MourtzouchosDepartment of Otorhinolaryngology, Pediatric Hospital "Karamandanio", Erythrou Stavou 40, 26331, Patras, Greece.
Magdalini TsiakouDepartment of Otorhinolaryngology, Pediatric Hospital "Karamandanio", Erythrou Stavou 40, 26331, Patras, Greece.
Athanasios AsimakopoulosDepartment of Otorhinolaryngology, Pediatric Hospital "Karamandanio", Erythrou Stavou 40, 26331, Patras, Greece.
General Hospital Pediatric Karamandanio · GRGeneral University Hospital of Patras · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2, the responsible virus for the COVID-19 pandemic, has demonstrated neurotropic properties indicated by cases presenting with auditory and vestibular system insults. The expression of ACE-2 receptors in the placenta and the detection of IgM antibodies against the virus in the fetuses of pregnant women suffering from COVID-19 render vertical transmission of the infection to the fetus possible. Thus, our study aims to examine whether, similar to other viruses like CMV, SARS-CoV-2 is responsible for congenital hearing loss. This is a retrospective study in a regional pediatric hospital. The medical records of newborns (n = 111) born by mothers positive for COVID-19 during pregnancy who underwent screening hearing tests with Transient Evoked Otoacoustic Emissions (TEOAE) and Automatic Auditory Brainstem Response (AABR) from February 2020 to June 2022 were reviewed. Neonates with additional aggravating factors for congenital hearing loss were excluded from the study. For the study period, nine mothers were found positive during the first trimester, twenty mothers in the second trimester, and eighty-three mothers in the third trimester. TEOAEs test and AABR test scored PASS bilaterally in all neonates tested.

conclusionInfection with COVID-19 during pregnancy was not a risk factor for hearing loss, similar to other studies. WHAT IS KNOWN: • The pathogenetic mechanism of the viral-induced impairment of the organ of Corti includes direct damage to the hair cells and indirect damage due to the induction of the innate inflammatory response. • Early data suggested that the SARS-CoV-2 virus also has neurotropic properties with manifestations from the sensory epithelia. WHAT IS NEW: • Although the intrauterine infection remains controversial, the expression of the ACE-2 receptor on the placenta and the detection of IgM antibodies, as well as the covid-19 genome in fetuses, make the vertical transmission tenable. • In our study, the newborn hearing screening results indicate that COVID-19 infection during pregnancy is not a risk factor for hearing loss.

Indexed as

COVID-19Hearing LossHearing Loss, SensorineuralChildEvoked Potentials, Auditory, Brain StemFemaleHearingHearing TestsHumansImmunoglobulin MInfant, NewbornMothersNeonatal ScreeningPandemicsPregnancyRetrospective StudiesImmunoglobulin MCongenital hearing lossCOVID-19Screening audiology testsTEOAEs

Identifiers

PMID36565323
PMCPMC9789365
OpenAlexW4313278122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.